Malaria Diagnostics Market to Surge Beyond $ 900 Mn By 2026

The Global Malaria Diagnostics Market Market Size is Projected to Reach US$ 900 Million by 2026 and is expected to witness 5.9% CAGR during the forecast period 2019 to 2026.

An increased incidence of tropical illness in endemic nations, new diagnostic methods are developed and increased investments are anticipated to boost market growth by regional governments and private sector investors. Malaria is one of life’s most common threateners, often caused by altering climate, low economic growth, poor health infrastructure and a absence of access for sophisticated therapy in tropical and subtropical areas.

There are also anticipations to fuel market growth in the near future, with an increasing amount of governments ‘ projects and market participants investing. Major businesses are conducting numerous malarial elimination programs to decrease the incidence of the disease. For example, the Malaria Initiative of Novartis was directed at enabling the elimination and control of malaria. In cooperation with different institutions, 750 million individuals in 60 nations have been supplied with non-profit therapy. This means the development of new technology and market penetration support are expected to be facilitated.

Modern technology has revolutionized and is in high demand the diagnosis of malaria. These studies have demonstrated that malaria antigen parasites have been detected effectively. The demand for malario diagnostic is expected to increase with the increase of public financing to the healthcare industry, combined to rising investment in research and development of new therapeutics.

Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1465

The WHO reports that in 2012 there were approximately 203 million global reports of malaria. Malaria caused around 627,000 fatalities worldwide the same year. To curb the spread of malaria governments in developing and undeveloped countries in particular, there is no stone left unturned. This encourages advanced malaria diagnosis. There are also incentives for individuals residing in distant areas to provide them at a pocket-friendly or nominal price.

Early and accurate diagnosis can contribute to malaria therapy and guarantee quick discovery. Therefore, investments in multiple diagnostic methods have increased on the market of malaria diagnostics. Malaria detection by microscopy and blood testing is included. Malaria diagnostic procedures are used to detect the occurrence of microscopically active parasites, such as molecular diagnoses, Rapid Diagnostic Tests (RDTs).

The market in Europe and Asia Pacific is anticipated to experience exponentially elevated demand as these areas have elevated malaria incidence. Moreover, the government’s efforts to increase awareness of the illnesses, their therapy and prevention should provide a important boost to the industry in malaria diagnosis. In Asia Pacific and in the rest of the world, this situation is most common across emerging nations. For example, the Government of India has invested heavily in awareness-raising of malaria prevention and cure. The nation also has increasing spending on healthcare.

This market is confronted with difficulties in accelerating diagnostic test adoption and use of malaria diagnosis. The WHO has updated its malaria rules and advises the analysis of all suspected malaria instances. Global partners ‘ initiatives to ensure universal access to diagnostic kits were conducted.

View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/malaria-diagnostics-market

Key Findings

The microscopic technology segment has motivated the traditional use of microscopic testing to detect malarial parasites.

RDTs will account for the biggest share of revenues due to easy use, comfort and quick diagnosis.

Due to their precision and ability to detect small parasite numbers, molecular diagnostic testing is expected to be the fastest growing technology segment during the provision era.

As a result of the elevated incidence of diseases and enhanced application of different malarial diagnostic methods in the region, Africa resulted the market in malaria diagnostics in 2018.

Key Players & Strategies

Some of the main businesses include bioMérieux; Beckman Coulter, Inc.; Access Bio., Inc. Sysmex Partec GmbH; Abbott Laboratories; Nikon Corporation; Siemens Healthineers; and Olympus Corp. Their large worldwide presence and distribution channels are responsible, in specific, for Abbott; bioMérieux; Siemens Healthineers; Beckman Coulter Inc.; and Bio-Rad Laboratories, Inc. For example, bioMérieux has a vast network of retailers across 42 diagnostic solutions in more than 150 nations.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Malaria Diagnostics
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Malaria Diagnostics Market By Technology
1.2.2.1. Global Malaria Diagnostics Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.2.2. Global Malaria Diagnostics Market Revenue Share By Technology in 2017
1.2.2.3. Molecular Diagnostic Tests
1.2.2.4. Real-Time PCR (qPCR)
1.2.2.5. Conventional PCR
1.2.2.6. Rapid Diagnostic Tests
1.2.2.7. Microscopy
1.2.3. Malaria Diagnostics Market by Geography
1.2.3.1. Global Malaria Diagnostics Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.3.2. North America Malaria Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.3.3. Europe Malaria Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.3.4. Asia-Pacific Malaria Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.3.5. Latin America Malaria Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.3.6. Middle East and Africa (MEA) Malaria Diagnostics Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Malaria Diagnostics Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Malaria Diagnostics Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Malaria Diagnostics Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Malaria Diagnostics Major Manufacturers in 2017

CHAPTER 4. MALARIA DIAGNOSTICS MARKET BY TECHNOLOGY

4.1. Global Malaria Diagnostics Revenue By Technology
4.2. Molecular Diagnostic Tests
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. Real-Time PCR (qPCR)
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.4. Conventional PCR
4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.5. Rapid Diagnostic Tests
4.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.6. Microscopy
4.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 5. NORTH AMERICA MALARIA DIAGNOSTICS MARKET BY COUNTRY

5.1. North America Malaria Diagnostics Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2. North America Malaria Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
5.3. U.S.
5.3.1. U.S. Malaria Diagnostics Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
5.4. Canada
5.4.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
5.5. Mexico
5.5.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

CHAPTER 6. EUROPE MALARIA DIAGNOSTICS MARKET BY COUNTRY

6.1. Europe Malaria Diagnostics Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2. Europe Malaria Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. UK
6.3.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
6.4. Germany
6.4.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
6.5. France
6.5.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
6.6. Spain
6.6.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
6.7. Rest of Europe
6.7.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

CHAPTER 7. ASIA-PACIFIC MALARIA DIAGNOSTICS MARKET BY COUNTRY

7.1. Asia-Pacific Malaria Diagnostics Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2. Asia-Pacific Malaria Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. China
7.3.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
7.4. Japan
7.4.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
7.5. India
7.5.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
7.6. Australia
7.6.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
7.7. South Korea
7.7.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
7.8. Rest of Asia-Pacific
7.8.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

CHAPTER 8. LATIN AMERICA MALARIA DIAGNOSTICS MARKET BY COUNTRY

8.1. Latin America Malaria Diagnostics Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. Latin America Malaria Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. Brazil
8.3.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
8.4. Argentina
8.4.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
8.5. Rest of Latin America
8.5.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

CHAPTER 9. MIDDLE EAST MALARIA DIAGNOSTICS MARKET BY COUNTRY

9.1. Middle East Malaria Diagnostics Market Revenue and Growth Rate, 2015 – 2026 ($Million)
9.2. Middle East Malaria Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Saudi Arabia
9.3.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.4. UAE
9.4.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.5. Rest of Middle East
9.5.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

CHAPTER 10. AFRICA MALARIA DIAGNOSTICS MARKET BY COUNTRY

10.1. Africa Malaria Diagnostics Market Revenue and Growth Rate, 2015 – 2026 ($Million)
10.2. Africa Malaria Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. South Africa
10.3.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.4. Egypt
10.4.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.5. Rest of Africa
10.5.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

CHAPTER 11. COMPANY PROFILE

11.1. bioMérieux
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. Beckman Coulter, Inc.
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. Access Bio, Inc
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. Sysmex Partec GmbH
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. Abbott Laboratories
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. Nikon Corporation
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies
11.7. Siemens Healthineers
11.7.1. Company Snapshot
11.7.2. Overview
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. Key Developments
11.7.6. Strategies
11.8. Olympus Corp
11.8.1. Company Snapshot
11.8.2. Overview
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. Key Developments
11.8.6. Strategies
11.9. Leica Microsystems GmbH
11.9.1. Company Snapshot
11.9.2. Overview
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. Key Developments
11.9.6. Strategies
11.10. Bio-Rad Laboratories, Inc.
11.10.1. Company Snapshot
11.10.2. Overview
11.10.3. Financial Overview
11.10.4. Product Portfolio
11.10.5. Key Developments
11.10.6. Strategies
11.11. Others
11.11.1. Company Snapshot
11.11.2. Overview
11.11.3. Financial Overview
11.11.4. Product Portfolio
11.11.5. Key Developments
11.11.6. Strategies

CHAPTER 12. RESEARCH APPROACH

12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope

Buy this premium Research Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1465

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.